News and Announcements
Top 5 Sectors In Australia For Investing
- Published December 20, 2022 2:22AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
FIVE sectors together got almost 50% of the 10B dollars invested in Australian companies in 2021. 😵
Here’s a breakdown:
1. FinTech $2.5B (25% of the total)
2. Enterprise/Business Software $970M (10% of the total)
3. PropTech/ RealTech/ Construction $683M (7% of the total)
4. MarTech/ EdTech/ SalesTech $672M (7% of the total)
5. BioTech/ MedTech $573M (6% of the total)
Unsurprisingly, Blockchain/Crypto/Web3 startups saw the largest percentage gain in deal count – $227M in 20 deals in 2021, up from just one in 2020.
Other smaller but fast-growing sectors of note included Marketplaces (36x 2021 vs 9x 2020), Social Networking/Media (23x 2021 vs 8x 2020), and DevTech/Developer Tools (14x 2021 vs 7x 2020).
[data from The state of Australian Startup Funding 2021]
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
